Manju Sengar, Arvind Vaidyanathan, Hasmukh Jain, Bhausaheb Bagal, Lingaraj Nayak, Alok Shetty, Girish B.S., Meghana C.S., Anupa John, Thomas Eipe, Neha Sharma, Kunjal Somaiya. "A prospective observational study to compare the efficacy, time toxicity, and cost of conventional 3+7 regimen versus azacitidine + venetoclax (AZA + VEN) as induction therapy in patients with acute myeloid leukemia (AML).." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.6511